Evidence map›Paper›PMID 21730054›Full record

ArticleThe Journal of biological chemistry2011

Involvement of protein kinase Cdelta/extracellular signal-regulated kinase/poly(ADP-ribose) polymerase-1 (PARP-1) signaling pathway in histamine-induced up-regulation of histamine H1 receptor gene expression in HeLa cells.

Hiroyuki Mizuguchi, Takuma Terao, Mika Kitai, Mitsuhiro Ikeda, Yoshiyuki Yoshimura, Asish Kumar Das, Yoshiaki Kitamura, Noriaki Takeda, Hiroyuki Fukui

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 67 citations in OpenAlex.

  1. Histamine HPharmaceuticals (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Histamine HInternational journal of molecular sciences · 2024
    Article
  4. Article
  5. Function and Role of Histamine HPharmaceuticals (Basel, Switzerland) · 2023
    Review
  6. Article
  7. Review
  8. Molecular Signaling and Transcriptional Regulation of Histamine HCurrent topics in behavioral neurosciences · 2022
    Review
  9. Signaling Pathway of Histamine HCurrent issues in molecular biology · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hiroyuki MizuguchiDepartments of Molecular Pharmacology, Tokushima 770-8505, Japan.
Takuma TeraoDepartments of Molecular Pharmacology, Tokushima 770-8505, Japan.
Mika KitaiDepartments of Molecular Pharmacology, Tokushima 770-8505, Japan.
Mitsuhiro IkedaDepartments of Molecular Pharmacology, Tokushima 770-8505, Japan.
Yoshiyuki YoshimuraMedical Pharmacology, Tokushima 770-8505, Japan.
Asish Kumar DasDepartments of Molecular Pharmacology, Tokushima 770-8505, Japan.
Yoshiaki KitamuraOtolaryngology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima 770-8505, Japan.
Noriaki TakedaOtolaryngology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima 770-8505, Japan.
Hiroyuki FukuiDepartments of Molecular Pharmacology, Tokushima 770-8505, Japan. Electronic address: hfukui@ph.tokushima-u.ac.jp.
Tokushima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The histamine H(1) receptor (H1R) gene is up-regulated in patients with allergic rhinitis. However, the mechanism and reason underlying this up-regulation are still unknown. Recently, we reported that the H1R expression level is strongly correlated with the severity of allergic symptoms. Therefore, understanding the mechanism of this up-regulation will help to develop new anti-allergic drugs targeted for H1R gene expression. Here we studied the molecular mechanism of H1R up-regulation in HeLa cells that express H1R endogenously in response to histamine and phorbol 12-myristate 13-acetate (PMA). In HeLa cells, histamine stimulation caused up-regulation of H1R gene expression. Rottlerin, a PKCδ-selective inhibitor, inhibited up-regulation of H1R gene expression, but Go6976, an inhibitor of Ca(2+)-dependent PKCs, did not. Histamine or PMA stimulation resulted in PKCδ phosphorylation at Tyr(311) and Thr(505). Activation of PKCδ by H(2)O(2) resulted in H1R mRNA up-regulation. Overexpression of PKCδ enhanced up-regulation of H1R gene expression, and knockdown of the PKCδ gene suppressed this up-regulation. Histamine or PMA caused translocation PKCδ from the cytosol to the Golgi. U0126, an MEK inhibitor, and DPQ, a poly(ADP-ribose) polymerase-1 inhibitor, suppressed PMA-induced up-regulation of H1R gene expression. These results were confirmed by a luciferase assay using the H1R promoter. Phosphorylation of ERK and Raf-1 in response to PMA was also observed. However, real-time PCR analysis showed no inhibition of H1R mRNA up-regulation by a Raf-1 inhibitor. These results suggest the involvement of the PKCδ/ERK/poly(ADP-ribose) polymerase-1 signaling pathway in histamine- or PMA-induced up-regulation of H1R gene expression in HeLa cells.

Indexed as

Gene Expression Regulation, NeoplasticButadienesCalciumCarbazolesEnzyme ActivationEnzyme InhibitorsExtracellular Signal-Regulated MAP KinasesHeLa CellsHistamineHumansNitrilesPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) PolymerasesPromoter Regions, GeneticProtein Kinase C-deltaProtein TransportButadienesCalciumCarbazolesEnzyme InhibitorsExtracellular Signal-Regulated MAP KinasesGo 6976HistamineNitrilesPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) PolymerasesProtein Kinase C-deltaReceptors, Histamine H1RNA, MessengerU 0126

Identifiers

PMID21730054
PMCPMC3162414
OpenAlexW2015026028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.